Statement from Agriculture Secretary Tom Vilsack on the 2024 Farm Sector Income Forecast

WASHINGTON, Feb. 7, 2024 – Today, the U.S. Department of Agriculture’s (USDA) Economic Research Service released its annual Farm Sector Income Forecast report for 2024. Agriculture Secretary Tom Vilsack issued the following statement:

“After the three highest consecutive years on record in 2021-2023, the first farm income forecast of 2024 indicates net farm income this year will return to prior levels. During this period of record farm income, U.S. farmers rose to the occasion by producing strong harvests and increasing commodity stocks while the U.S. economy recovered more quickly and more robustly than that of the global economy from COVID-19. As a result, while we have rebuilt the global supply, we are seeing a decreased demand for U.S. commodities and commodity prices are coming down. At the same time, while some production costs have come down, others, including labor, pesticides, and livestock purchases, have increased. This brings us to the slightly below historic levels for farm income forecasted today.

“The forecast underscores the critical importance of USDA’s ongoing work to help foster prosperity for producers and the communities they love by supporting an economy that grows from the bottom up and the middle out, and by creating new market opportunities that promote competition in the marketplace that can help combat low prices and high input costs.

“Under the Biden-Harris Administration, USDA has taken unprecedented actions to level the playing field so small and mid-sized farmers can get a fair price for their products, while making billions of dollars in transformative investments through the American Rescue Plan and Inflation Reduction Act to create new markets and new income opportunities for family farmers. USDA will continue to focus its efforts on enhancing economic resiliency and robust price competition, increasing farmers’ and ranchers’ earnings, increasing the ability to compete, and keeping farming viable and rural communities thriving.”

#

USDA is an equal opportunity provider, employer, and lender.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
As Omicron Soars, Biden Announces Hospital Relief, Free Tests thumbnail

As Omicron Soars, Biden Announces Hospital Relief, Free Tests

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. With the Omicron variant of the coronavirus blazing across the United States, President Joe Biden offered reassurance on Tuesday to Americans who have followed public health guidance to get vaccinated and boosted, and delivered a stark warning to those who haven't.…
Read More
Slush ice drinks linked to Illness in children thumbnail

Slush ice drinks linked to Illness in children

Excessive consumption of slush ice drinks over a short time period has been linked to two children falling sick in Scotland. Food Standards Scotland (FSS) said it was aware of two children, in Edinburgh in 2022 and Lanarkshire in 2021, who became unwell after having slush ice drinks. Both required hospitalization and had symptoms consistent
Read More
The Emotional Effects of OAB thumbnail

The Emotional Effects of OAB

Please enable cookies. Error 1005 Ray ID: 88cdb7e60f783e27 • 2024-06-01 08:08:53 UTC What happened? The owner of this website (www.webmd.com) has banned the autonomous system number (ASN) your IP address is in (47583) from accessing this website. Was this page helpful? Thank you for your feedback! Cloudflare Ray ID: 88cdb7e60f783e27 • Your IP: 185.124.111.116 •
Read More
Antisense Oligonucleotide Shows Potential in Dravet Syndrome thumbnail

Antisense Oligonucleotide Shows Potential in Dravet Syndrome

Meeting Coverage > AES — Investigational STK-001 appears well tolerated in early studies by Judy George, Deputy Managing Editor, MedPage Today December 9, 2022 Last Updated December 12, 2022 Multiple doses of STK-001, an investigational antisense oligonucleotide to treat Dravet syndrome, were well tolerated and showed trends toward fewer seizures, interim analyses of phase I/IIa
Read More
Index Of News